Hematopoietic Stem Cell Expansion via Wnt and DNMT Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for expanding hematopoietic stem cells (HSCs) lack understanding of molecular regulation, particularly in the interaction between Wnt and PTEN signaling pathways, which hinders effective expansion and differentiation, and there is a need for methods to increase HSC numbers for transplantation while minimizing the risk of tumorigenesis.
Innovation Solution
An ex vivo method involving a culture medium with DNA methyltransferase inhibitors (DNMTi) and GSK-3β inhibitors to modulate the Wnt pathway, allowing for the expansion of HSCs while maintaining their undifferentiated state and multilineage potential, thereby increasing their number and functional capacity for transplantation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If HSCs are activated for expansion, then the number of HSCs increases, but the risk of tumorigenesis increases and self-renewal capacity is depleted
Solution Approach 1:
The patent applies parameter changes by modulating specific signaling pathways (Wnt/β-catenin and PI3K/Akt) through targeted inhibitors and activators. By changing the activity state of these pathways rather than broadly activating all cellular processes, the method achieves HSC expansion while controlling tumorigenesis risk through precise molecular parameter adjustment
Solution Approach 2:
The patent uses pathway modulators as intermediaries to mediate between the goal of HSC expansion and the constraint of preventing tumorigenesis. These molecular intermediaries (inhibitors and activators) transmit controlled signals that promote expansion while maintaining safety, acting as mediators between opposing requirements
2Quantity of substance
If HSCs are activated for expansion, then the number of HSCs increases, but the self-renewal capacity is depleted
Solution Approach 1:
The patent employs parameter changes by transiently activating specific pathways during expansion phases and then returning to quiescent states. This dynamic parameter adjustment allows HSCs to proliferate when needed while preserving long-term self-renewal capacity by avoiding permanent activation
Solution Approach 2:
The patent implements periodic action through alternating phases of activation and quiescence. HSCs undergo cycles of controlled proliferation followed by rest periods, which prevents exhaustion of self-renewal capacity while achieving necessary expansion numbers over time
3Productivity
If molecular regulation pathways are better understood and targeted, then HSC expansion efficiency increases, but the complexity of the method increases
Solution Approach 1:
The patent applies segmentation by dividing the complex molecular regulation into distinct, targetable pathways (Wnt/β-catenin and PI3K/Akt). Each pathway is controlled by specific modulators, breaking down the complex process of HSC expansion into manageable, independently controllable segments that can be optimized separately
Data Source
AI summary
Methods and kits for expanding a stem cell population, particularly a hematopoietic stem cell population, in the presence of a DNA methyltransferase modulator and a Wnt pathway modulator are disclosed.